 
  
  |
院長紹介 髙見 武志（たかみ たけし）
Who's Who に登録されました。  クリック！
Who's Who in the World 2011 28th Edition Marquis 2574-2575(2010)
2011,2012,2013,2014,2015,2016年と６年連続掲載
Who's Whoとは？ 
Who's Who in the World 2016 33th Edition Marquis
TAKAMI, TAKESHI, immunologist, director, physician; b. Kakogawa, Hyogo, Japan, Nov. 21, 1950; BS in Biology, Osaka Ednl. U., Japan, 1974; MD, Nara Med. U., 1983; PhD, Kinki U., 1993. Cert. physician Japan, Japanese Bd. Gen. Physician. Rsch. fellow dept. immunology Osaka U., 1974–77, 1983–84; physician, divsn. internal medicine Seikeikai Hosp., Osaka, Japan, 1984–93; dir. Clinic Jingumae, 1993–. Rsch. fellow dept. pathology Kinki U., Japan, 1986–93, part time lectr. dept. pathology, 1995–2003; part time lectr. dept. 1st internal medicine Nara Med. U., Japan, 2002–; dir. Nara Med. Assn., Japan, 2010–; mem. editl. bd. Jour. Advanced Clin. Pharmacology, 2014–, Jour. Cardiovas. Disorders, 2014–. Recipient award, Japanese Soc. Allergy, 1974, Japanese Gen. Physician, 2010, Cmty. Based Study Encouragement prize, Japaneses Soc. Hypertension, 2012, Case Presentation award, Japanese College of Cardiology, 2013, Practical Med. Excellent award, Japaneses Soc. Hypertension, 2015, award, Japanese Gen. Physician, 2016, Japanese Minister of Health, Labour and Welfare commendation, Social Ins. Med. Treatment Reward Payment Fund Achievement, 2016. Fellow: Japanese Soc. Hypertension (councillor 2003–); mem.: Japanese Coll. Cardiology, Japanese Soc. Geriatrics, Japanese Soc. Internal Medicine (councillor 2013–), Japanese Soc. Atherosclerosis (councillor 2011–), Japanese Soc. Circulation. Liberal. Buddhist. Achievements include research in the role of hapten-reactive T lymphocyte in the induction of autoimmunity; evaluation of arterial stiffness; evaluation of central blood pressure; evaluation of left ventricular hypertrophy and diastolic function; experimental and clinical hypertension; effects of RAS inhibitter on cardiovascular enents; effect of smoking on central blood pressure;Clinical interaction between brain and kidney in small vessel disease; effect of visit to visit BP variability on left ventricular hypertrophy and diastolic function. Avocations: gardening, archaeology, travel. Office: 1F Confort Yagi 5-4-41 Naizenchou Kashihara Nara 634-0804 Japan Business E-Mail: takami66@m5.kcn.ne.jp.
Takeshi Takami Presented with the Albert
Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
Dr. Takami has been endorsed by Marquis
Who's Who as a leader in medicine
KASHIHARA NARA, JAPAN, February 12, 2018 /24-7PressRelease/ -- Marquis
Who's Who, the world's premier publisher of biographical profiles, is proud
to present Takeshi Takami, MD, PhD, with the Albert Nelson Marquis Lifetime
Achievement Award. An accomplished listee, Dr. Takami celebrates many years
of experience in his professional network, and has been noted for achievements,
leadership qualities, and the credentials and successes he has accrued
in his field. As in all Marquis Who's Who biographical volumes, individuals
profiled are selected on the basis of current reference value. Factors
such as position, noteworthy accomplishments, visibility, and prominence
in a field are all taken into account during the selection process.
Dr. Takami was born in Kakogawa, Hyogo, Japan in November 1950. He has
been a general physician and director of the Clinic of Jingumae since 1993.
In addition, he has served as a part-time lecturer in the department of
internal medicine with Nara Medical University since 2002, having been
a part-time lecturer with the Kinki University department of pathology
from 1995 to 2003. Prior to obtaining these roles, he worked as a staff
physician with the Seikeikai Hospital division of internal medicine from
1984 to 1993.
Dr.
Takami began his career as a student at Osaka Educational University, obtaining
a Bachelor of Science in biology in 1974. He served in a research fellowship
with the Osaka University department of immunology from 1974 to 1977, and again
from 1983 to 1984 after completing an MD with Nara Medical University in 1983.
He later earned a PhD with Kinki University in 1993. He is certified by the
Japan Medical Association.
A
respected voice in the field, Dr. Takami has served on the editorial board of
the Journal of Cardiovascular Disorders and the Journal of Advanced Clinical
Pharmacology, and he is the director of the Nara Medical Association. He is
known for his research in the role of hapten-reactive T lymphocyte in the
induction of autoimmunity, evaluation of arterial stiffness, evaluation of
central blood pressure, evaluation of left ventricular hypertrophy and
diastolic function, experimental and clinical hypertension, effects of RAS
inhibitter on cardiovascular enents, effect of smoking on central blood
pressure, clinical interaction between brain and kidney in small vessel
disease, and the effect of visit to visit BP variability on left ventricular
hypertrophy and diastolic function.
Dr.
Takami is an elected fellow of the Japanese Society of Hypertension and
councilor for the organization for the past 15 years. He is also an active
member of the Japanese College of Cardiology, the Japanese Society of
Geriatrics, the Japanese Society of Internal Medicine, the Japanese Society of
Atherosclerosis, and the Japanese Society of Circulation.
Dr.
Takami has received several awards and accolades for his work, including with a
Japanese Minister of Health, Labor, and Welfare Commendation. He was the
recipient of a Social Insurance Medical Treatment Reward Payment Fund
Achievement, a Japanese General Physician Award, a Practical Medical Excellent
Award, and a Community Based Study Encourage Prize from the Japanese Society of
Hypertension, and a Case Presentation Award from the Japanese College of
Cardiology. Dr. Takami has been included in every edition of Who's Who in the
World since 2011.
In recognition of outstanding contributions to his profession and the Marquis
Who's Who community, Takeshi Takami, MD, PhD, has been featured on the
Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com
for more information about this honor.
当院は私の専門領域である循環器・高血圧を中心に、専門性の高い先進的な医療のご提供を通じて、患者さんに最適な医療を行なっております。院内設備・紹介病院との連携体制など、「ホームドクター」としてより専門性の高い医療のご提供を目指しております。どんな症状でも気軽にご相談ください。
院長の研究基盤
大阪大学医学部腫瘍発生学教室（北川正保教授、浜岡利之教授）の教室で免疫学の研究：ハプテンに反応するＴ細胞の発見とそれを利用した自己免疫疾患、腫瘍免疫の研究。
近畿大学医学部病理学教室（岡本耕造教授、鈴木庸之教授）の教室で実験病理学の研究：高血圧の臓器障害の研究および脳、心、腎、血管の高血圧性病変の研究を高血圧自然発症ラットを用いて研究。高血圧における延髄のカテコールアミンの研究。高血圧と各種ホルモンの研究。
院長の臨床基盤
高血圧、脳血管障害を中心に循環器系の救急からリハビリまでを清恵会病院内科で臨床経験
クリニック神宮前でプライマリーケアー、在宅診療、高血圧、糖尿病、脂質異常症、睡眠時無呼吸症候群等生活習慣病、心房細動等の不整脈、心不全、狭心症等循環器疾患や腎臓病等の生活習慣病に起因する疾患の管理。
略歴
昭和44年 3月 兵庫県立加古川東高校卒業
昭和44年 4月 大阪教育大学特別理学課程生物学専攻入学
昭和47年11月 大阪大学医学部癌研究施設研究員
昭和49年 3月 大阪教育大学特別理学課程生物学専攻卒業
昭和49年 4月 大阪大学医学部研究副手
昭和49年10月 日本アレルギー学会特別演題賞受賞
昭和52年 4月 奈良県立医科大学医学部入学
昭和58年 3月 奈良県立医科大学医学部卒業
昭和58年 4月 大阪大学医学部研究生
昭和59年 6月 医療法人清恵会病院内科（医員、医長、部長）
平成 5年 6月 医学博士
平成 5年10月 クリニック神宮前院長（現職）
平成 6年 4月 近畿大学医学部非常勤講師（第１病理）平成15年3月まで
平成10年 3月 橿原地区医師会理事 平成20年まで
平成11年 6月 奈良県社会保険診療報酬支払基金審査員 (現職）
平成14年 4月 奈良県立医科大学医学部医学科非常勤講師（第１内科)平成30年3月まで
平成15年 3月 なら健康増進戦略会議健康情報部会委員 平成21年まで
平成15年 4月 独立行政法人奈良文化財研究所産業医（令和4年3月まで）
平成16年 4月 日本高血圧学会特別正会員（現職）
平成16年 9月 日本高血圧学会評議員（平成２８年まで）、
ありかた委員会委員（平成18年まで）
平成19年 6月 奈良県社会保険診療報酬支払基金主任審査員（現職）
平成20年 3月 橿原地区医師会監事,奈良県医師会予備代議員 平成22年3月まで
平成21年 6月奈良県社会保険診療報酬支払基金再審査部会会長(現職）
平成22年 3月 奈良県医師会理事（平成２９年６月まで）
平成22年10月日本臨床内科医学会学会長賞受賞
平成23年７月 日本動脈硬化学会評議員（平成２９年まで）
平成23年9月 奈良県庁地域福祉課嘱託医（現職）
平成24年５月 第１回日本高血圧学会臨床高血圧フォーラム地域密着型研究奨励賞受賞
平成25年４月 日本内科学会評議員（平成２７年まで）
平成25年9月 第61回日本心臓病学会 Case Presentation Award 受賞
平成25年12月Editional Board:JournalofAdvanced Clinical Pharmacology(平成27年まで）
平成26年7月Editional Board: Journalof Cardiovascular Disorder(現職）
平成26年9月奈良県てんかん診療ネットワーク研究会世話人（現職）
平成26年9月奈良県国民健康保険団体連合会保険事業支援評価委員会副委員長（平成29年まで
平成27年5月 第４回日本高血圧学会臨床高血圧フォーラム実地医療優秀賞受賞
平成28年2月 奈良地方裁判所委員会委員（令和2年まで）
平成28年４月 奈良県中和福祉事務所嘱託医（現職）
平成28年4月 奈良地方裁判所民事調停委員（令和4年3月まで））
平成28年10月日本臨床内科医学会学会長賞受賞
平成28年10月 厚生労働大臣表彰（社会保険診療報酬基金功労）
平成28年10月 日本医師会生涯教育推進委員会委員（平成30年6月まで）
平成29年４月 日本動脈硬化学会功労会員（現職）
平成30年3月Editional Board:Journal of Clinical Pharmacology and Toxicology（平成30年6月まで）
平成30年4月 奈良県立医科大学循環器内科非常勤講師（現職）
平成30年4月厚生労働省近畿厚生局奈良事務所保険指導医（現職）
平成30年5月 第7回日本高血圧学会臨床高血圧フォーラム実地医療優秀賞受賞
平成30年5月 日本高血圧学会実地医家部会委員（現職）
平成31年2月 静電場スクリーン研究会メディカルアドバイザー（現職）
令和1年10月 日本高血圧学会実地医家部会委員（JDOME, 実地医家AWARD、臨床研究、 シンポジウム担当）（現職）
令和1年12月 日本高血圧学会実地医家部会アワード選定ワーキンググループ委員長
（令和５年まで））
令和1年12月 日本高血圧学会実地医家部会セッションプログラム作成ワーキンググループ 委員（現職）日本高血圧学会実地医家部会デジタル化推進WG委員（現職）
日本高血圧学会会実地医家部会実地医家J-DOME WG委員（現職）
令和2年11月 日本高血圧学会J-DOME事業TF（タスクフォース）委員会委員（現職）
日本高血圧学会実地医家部会中央委員（現職）
令和4年10月 日本高血圧学会2025年ガイドライン統括委員会委員（現職）
Editional Board
Jornal of Cardiovascular Disorder
Journal Referee Reading
Journal of Human Hypertension,
Hypertension Research,
Journal of Hypertension (Supl)
Vascular Health and Risk Management
Cardiovascular Diabetology
Neurological Research
Therapeutics
and Clinical Risk Management
Patient
Preference and Adherence
Integrated
Blood Pressure Control
Journal Drugs in R&D
Circulation Journal
BMC Cardiovascular Disorders
Mount Sinai Journal Medicine
主な現職
クリニック神宮前 院長
奈良県立医科大学 非常勤講師（循環器内科）
日本高血圧学会 特別正会員, J-DOME事業TF委員会委員 ,実地医家部会中央委員
日本高血圧学会2025年ガイドライン統括委員会委員
日本動脈硬化学会 功労会員
奈良県社会保険診療報酬支払基金主任審査員,、再審査部会長
橿原市畝傍南小学校 校医
奈良県庁地域福祉課嘱託医
奈良県中和福祉事務所嘱託医
厚生労働省近畿厚生局奈良事務所保険指導医
国際学会学会発表
1) Takeshi Takami, Tsuneyuki
Suzuki and Kozo Okamoto
Changes in TSH and 11-deoxycorticosterone (DOC) in
hypertension.
6th International .Symposium. on SHR and Related Studies. 1989, Iowa, USA
2) Takeshi Takami
Effect of antihypertensive agents on platelet function in patients with
essential hypertension.
4th International Symposium. Cardiovascular .Pharmacotherapy(ISCP). 1991,
Geneva, Switzerland
3) Takeshi Takami
Heart and renal failure induced by steroid(from
circulation aspect)
26th International .Congress of Internal Medicine. 2002, Kyoto,Japan
4) JATOS study group (Masao Ishii , Takeshi Takami et al)
Large Clinical Trial JATOS
21th Scientific meeting of international society of
hypertension (ISH) 2006, Fukuoka
5) Takeshi Takami
Effect of high dose valsartan on arterial stiffness in masked hypertension
compared with valsaltan plus diuretic22nd ISH , 2008, Berlin, Germany
6) Takeshi Takami
Effect of high dose valsartan on arterial stiffness
in masked hypertension compared with valsaltan plus diuretic 18th ESH, 2008, Berlin, Germany
7) Takeshi Takami
Sacubitril/valsartan improves hypertension, nighttime blood pressure and heart failure
29th ISH, 2022, Kyoto, Japan
英文原著（代表的なもの）
1) Toshiyuki Hamaoka, Uki Yamashita, Takeshi Takami and Masayasu Kitagawa
The mechanism of tolerance induction in
thymus-derived lymphocytes.
The Journal of Experimental Medicine, 141, 1308-1328, 1975
2) Uki Yamashita, Takeshi
Takami and Masayasu Kitagawa
Induction of anti-hapten antibody responce by
hapten-isologous carrier conjugate.
Cellular Immunology 18, 369-410, 1975
3) Uki Yamashita, Toshiyuki Hamaoka, Takeshi Takami and Masayasu Kitagawa
Immune maturation of T lymphocye:Seqential changes in the functional specificity
and apperentaffinity of hapten-reactive helper T cells during an immune
response.
Cellular Immunology 22, 152-164,1976
4) Uki Yamashita, ,Takeshi
Takami, Toshiyuki Hamaoka and Masayasu Kitagawa
The role of hapten-reactive T lymphocytes in the
induction of autoimmunity in mice Ⅰ
Cellular Immunology. 25,15-31,1976
5) Uki Yamashita, Takeshi Takami, Toshiyuki Hamaoka and Masayasu
Kitagawa
The role of hapten-reactive
T lymphocytes in the induction of autoimmunity in miceⅡ
Cellular Immunology. 25, 32-40,1976
6) Takeshi Takami, Hiroyuki Ito,Tsuneyuki Suzuki and Kozo
Okamoto
Changes in TSH and 11-deoxycorticosterone(DOC) in hypertension
Clinical. and Experimental .Hypertension., A13,991-998,1991
7) Takeshi Takami ,Hiroyuki Ito and Tsuneyuki Suzuki
Decreased
norepinephrine content in the medulla oblongata in severely hypertensive rats.
Clinical and. Experimental. Pharmacolgy and. Physiology. 20, 161-167, 1993
8) Takeshi Takami, Minori Shigematu
Effects of calcium
channel antagonists on left ventricular hypertrophy and diastolic function in patients
with essential hypertension.
Clinical and Experimental Hypertension,25,525-535,2003
9) Takeshi Takami, Minori Shigematsu
Efficacy of various antihypertensive agents as evaluted by indices of vascularstiffness
in elderly hypertensive patients.
Hypertension Research,26, 609-614,2003
10) JATOS study group (Takeshi
Takami et al)
The Japanese trial to assess optimal systolic blood pressure in elderly
hypertensive patients
Hypertension Reseach 28,513-520,2005
11) JATOS study group(Takeshi Takami et al)
Principal result of the Japanese trial to assess optimal systolic blood
pressurein elderly hypertensive patients (JATOS)
Hypertension Research 31,2115-2127,2008
12) Takeshi Takami
Evaluation of arterial
stiffness in morning hypertension under high dose valsartan
compared to valsartan
plus low dose diuretic
Hypertension Research 32:1086-1090:2009
13) Takeshi Takami, Yoshihiko Saito
Differential Effects of Azelnidipine with OlmesaRTAn and Amlodipine with
Olmesartan on Central Blood Pressure and LVMI in Hypertensive Patients
(AORTA study).
Vascular Health and Risk Management. 7:383-390:2011.
14) Takeshi Takami,Yoshihiko Saito
Effects of smoking cessation on central bloood pressure and arterial stiffness.
Vascular Health and Risk Management.7:633-638:2011.
15) Takeshi Takami, Shigeru Yamano, Sadanori Okada, Mio Sakuma, Takeshi Morimoto, Hiroshi
Hashimoto, Satoshi Somekawa, Yoshihiko Saito
Major risk factors for the appearance of white matter lesions on MRI in
hypertensive patients with controlled blood pressure.
Vascular Health and Risk Management. 8:169-176:2012.
16) Takeshi Takami, Hiroshi Ito, Katsuhisa Ishii, Kenei Shimada, Katsunori Iwakura, Hiroyuki
Watanabe, Shota Fukuda, Junichi Yoshikawa
Adding thiazide to a renin-angiotensin blocker regimen to improve left
ventricular relaxation in diabetes and non-diabetes patients with hypertension.
Drug Design, Development and Therapy.6::225-233: 2012
17) Takeshi Takam,Yoshihiko Saito
Azelnidipine plus Olmesartan vs Amlodipine plus Olmesartan on Arterial
Stiffness and Cardiac Function in Hypertensive Patients: A randomized trial
Drug Design, Development and Therapy 7: 175-183: 2013
18) Shigeru Yamano, Manabu Horii, Takeshi Takami, Mio Sakuma,Takeshi Morimoto,,
Sadanori Okada, Toshiaki Taoka, Kimihiko Kichikawa, Hiroyuki Sasamura, Hiroshi Itoh,
Yoshiko Furuya, Satoshi Ueno, Tomoaki Imamura, Seigo Sugiyama, Hisao Ogawa,
Yoshihiko Saito
Comparison between angiotensin converting enzyme inhibitors and
angiotensin receptor blockers on the risk of stroke recurrence and longitudinal
progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL
study): Rationale, design, and methodology.
International Journal of Stroke, 10；,452–456::2015
19)Dai Ato, Takeshi Takami
Brachial-Ankle Pulse Wave Velocity, Mortality, and
Cardiovascular Events
Journal of Cardiovascular Disorder: ;2;:1009:1-11,2015
20) Takeshi Takami, Sadanori Okada, Yoshihiko Saito, Yoko Nishijima, Hiroyuki Kobori, Akira
Nishijima
Effects of olmesartan and
azilsartan on albuminuria and the intrarenal renin-angiotensin system
World Journal of Research and Review; 6: 7-10, 2018
21)Yoshihiro Takikawa, Takeshi Takami, Koji Kakutani
Body water-mediated conductivity actualized the insect-control functions
of electric fields in houseflies
Insect 11,561,, 2020
22)Koji Kakutani , Yoshinori Matsuda , Teruo Nonomura , Yoshihiro Takikawa
, Takeshi Takami
Hideyoshi Toyoda
A Simple Electrostatic Precipitator for Trapping Virus Particles Spread
via Droplet Transmission
International Journal of Environmental Research and Public Health;１８；４９４３：２０２１
23)Takeshi Takami , Satoshi Hoshida , Kazuomi Kario K
Differential impact of antihypertensive drugs on cardiovascular remodeling: A review of findings and perspectives for HFpEF prevention；
Hypertension Research 45, 53–60 ,2022
国際論文査読
1) Journal of Hypertension Suppl. 2008
2) Vascular Health and Risk Management 2010.
3) Integrated Blood Pressure Control 2010.
4) Vascular Health and Risk Management 2011.
5) Journal of Human Hypertension 2011.
6) Vascular Health and Risk Management 2012.
7) Therapeutics and Clinical Risk Management 2012.
8) Hypertension Research 2012.
9) Vascular Health and Risk Management 2012.
10) Therapeutics and Clinical Risk Management 2012.
11) Therapeutics and Clinical Risk Management 2012.
12) Cardiovascular Diabetology 2012.
13) The Most Sinai Journal of Medicine (MSJM) 2012.
14) Vascular Health and Risk Management 2012.
15) Vascular Health and Risk Management 2012
16) Patient Preference and Adherence 2012
17) Neurological Research 2012
18) Patient Preference and Adherence 2012
19) Integrated Blood Pressure Control 2013
20)Integrated Blood Pressure Control 2013
21) Vascular Health and Risk Management 2013
22)Integrated Blood Pressure Control 2013
23)Therapeutics and Clinical Risk Management 2013
24)Integrated Blood Pressure Control 2013
25)Vascular Health and Risk Management 2013
26) Journal Drugs in R&D.2013
27) Cardiovascular Disease iConcept Press Ltd 2013
28)Vascular Health and Risk Management 2013
29)Drug Design, Development and Therapy 2013
30)Vascular Health and Risk Management 2013
31)Therapeutics and Clinical Risk Management 2013
32)Vascular Health and Risk Management 2013
33)Integrated Blood Pressure Control 2014
34)Circulation Research 2014
35)Clinical Interventions in Aging 2014
36)Therapeutics and Clinical Risk Management 2014
37)Therapeutics and Clinical Risk Management 2015
38)Therapeutics and Clinical Risk Management 2015
39)Therapeutics and Clinical Risk Management 2015
40)Therapeutics and Clinical Risk Management 2015
41)BMC Cardiovascular Disorders 2015
42)Integrated Blood Pressure Control 2015
43)Therapeutics and Clinical Risk Management 2016
44)Vascular Health and Risk Management 2016
45)Therapeutics and Clinical Risk Management 2017
46)Therapeutics and Clinical Risk Management 2017
47)Therapeutics and Clinical Risk Management 2017
48)Integrated Blood Pressure Control 2018
49)Therapeutics and Clinical Risk Management 2018
50)Integrated Blood Pressure Control 2019
51)Integrated Blood Pressure Control 2019
52)Current Vascular Pharmacology 2019
53)Current Vascular Pharmacology2020
54)BMC Cardiovascular Disorders 2020
55)BMC Cardiovascular Disorders 2020
|
